Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
Edwards Lifesciences (NYSE: EW) has announced its participation in the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025. Scott Ullem, chief financial officer, will present at 9:50 a.m. ET.
A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.
Edwards Lifesciences is the leading global structural heart innovation company, focused on improving patient lives through breakthrough technologies and partnerships with healthcare stakeholders. The company's patient-focused culture drives its employees to deliver life-changing innovations to those who need them most.
Edwards Lifesciences (NYSE: EW) ha annunciato la sua partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen martedì 4 marzo 2025. Scott Ullem, direttore finanziario, presenterà alle 9:50 a.m. ET.
Una webcast dal vivo della presentazione sarà disponibile sul sito web delle relazioni con gli investitori di Edwards Lifesciences all'indirizzo http://ir.edwards.com/, con una versione archiviata accessibile più tardi nello stesso giorno.
Edwards Lifesciences è l'azienda leader mondiale nell'innovazione del cuore strutturale, focalizzata sul miglioramento della vita dei pazienti attraverso tecnologie rivoluzionarie e partnership con i soggetti del settore sanitario. La cultura orientata al paziente dell'azienda spinge i suoi dipendenti a fornire innovazioni che cambiano la vita a coloro che ne hanno più bisogno.
Edwards Lifesciences (NYSE: EW) ha anunciado su participación en la 45ª Conferencia Anual de Salud de TD Cowen el martes 4 de marzo de 2025. Scott Ullem, director financiero, presentará a las 9:50 a.m. ET.
Una transmisión en vivo de la presentación estará disponible en el sitio web de relaciones con inversores de Edwards Lifesciences en http://ir.edwards.com/, con una versión archivada accesible más tarde ese mismo día.
Edwards Lifesciences es la empresa líder mundial en innovación del corazón estructural, enfocada en mejorar la vida de los pacientes a través de tecnologías innovadoras y asociaciones con actores del sector salud. La cultura centrada en el paciente de la empresa impulsa a sus empleados a ofrecer innovaciones que cambian la vida a quienes más lo necesitan.
에드워즈 라이프사이언스 (NYSE: EW)는 2025년 3월 4일 화요일에 열리는 TD Cowen 제45회 연례 건강 관리 컨퍼런스에 참여한다고 발표했습니다. 스콧 울렘 최고재무책임자가 오전 9시 50분(동부 표준시)에 발표할 예정입니다.
발표의 실시간 웹캐스트는 에드워즈 라이프사이언스의 투자자 관계 웹사이트(http://ir.edwards.com/)에서 제공되며, 같은 날 나중에 아카이브 버전도 이용할 수 있습니다.
에드워즈 라이프사이언스는 구조적 심장 혁신 회사의 글로벌 리더로, 혁신적인 기술과 의료 이해관계자와의 파트너십을 통해 환자의 삶을 개선하는 데 집중하고 있습니다. 회사의 환자 중심 문화는 직원들이 가장 필요로 하는 사람들에게 삶을 변화시키는 혁신을 제공하도록 동기를 부여합니다.
Edwards Lifesciences (NYSE: EW) a annoncé sa participation à la 45e Conférence Annuelle sur la Santé de TD Cowen le mardi 4 mars 2025. Scott Ullem, directeur financier, présentera à 9h50, heure de l'Est.
Une diffusion en direct de la présentation sera disponible sur le site des relations investisseurs d'Edwards Lifesciences à l'adresse http://ir.edwards.com/, avec une version archivée accessible plus tard dans la journée.
Edwards Lifesciences est l'entreprise leader mondiale en innovation cardiaque structurelle, axée sur l'amélioration de la vie des patients grâce à des technologies révolutionnaires et à des partenariats avec les acteurs du secteur de la santé. La culture centrée sur le patient de l'entreprise pousse ses employés à fournir des innovations qui changent la vie de ceux qui en ont le plus besoin.
Edwards Lifesciences (NYSE: EW) hat seine Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen am Dienstag, den 4. März 2025, angekündigt. Scott Ullem, Finanzvorstand, wird um 9:50 Uhr ET präsentieren.
Ein Live-Stream der Präsentation wird auf der Investor-Relations-Website von Edwards Lifesciences unter http://ir.edwards.com/ verfügbar sein, mit einer später am selben Tag zugänglichen archivierten Version.
Edwards Lifesciences ist das führende globale Innovationsunternehmen im Bereich strukturelle Herzmedizin, das sich darauf konzentriert, das Leben von Patienten durch bahnbrechende Technologien und Partnerschaften mit Akteuren im Gesundheitswesen zu verbessern. Die patientenorientierte Kultur des Unternehmens motiviert die Mitarbeiter, lebensverändernde Innovationen für diejenigen bereitzustellen, die sie am dringendsten benötigen.
- None.
- None.
Scott Ullem, chief financial officer, is scheduled to present at 9:50 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.
About Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225805004/en/
Media Contact: Amy Hytowitz, 949-250-5070
Investor Contact: Mark Wilterding, 949-250-6826
Source: Edwards Lifesciences Corporation
FAQ
When will Edwards Lifesciences (EW) present at the TD Cowen Health Care Conference in 2025?
Who will represent Edwards Lifesciences (EW) at the TD Cowen conference in March 2025?
How can investors access Edwards Lifesciences' (EW) presentation at the TD Cowen conference?
What is Edwards Lifesciences' (EW) primary business focus according to their recent announcement?
Will Edwards Lifesciences (EW) make any product announcements at the March 2025 TD Cowen conference?
